Zahra Ramji: Revolutionizing Neuroendocrine Cancer Care
Zahra Ramji, Co-Founder at MedInsights Unleashed, shared MedInsights Unleashed‘s post on LinkedIn, adding:
“NEW EPISODE ALERT MedInsights Unleashed
Revolutionizing Neuroendocrine Cancer Care: Quality of Life Over Quantity of Treatment
Join John J Collins MBA EMT and I interview Professor Philip Agop Philip, MD, PhD, FRCP, expert oncologist Wayne State University School of Medicine and Henry Ford Cancer Institute as he demystifies neuroendocrine tumors (NETs), a rare but increasingly diagnosed cancer type due to advances in detection and survival.
Whether you are a healthcare professional, patient, or caregiver, this episode delivers critical insights to empower your journey.
Listen now on Apple, Spotify, YouTube and more.”
Quoting MedInsights Unleashed‘s post:
“New Episode : Quality of Life Over Quantity of Treatment: A Revolution in Neuroendocrine Cancer Care with Professor Philip, MD, PhD, FRCP
In our latest episode of MedInsights Unleashed, we’re joined by Professor Philip Agop Philip, MD, PhD, FRCP — Professor of Medical Oncology at Wayne State University and the Henry Ford Cancer Institute — who unpacks the often-misunderstood world of neuroendocrine tumors (NETs).
Key Takeaways for Healthcare Professionals:
- NETs are rare but increasingly diagnosed due to improved survival.
- Symptoms can be vague—biomarkers help, but biopsy remains essential.
- Ki67 grading is critical to guide treatment decisions.
- Specialist centers and second opinions lead to better outcomes.
For Patients and Caregivers:
- NETs are often chronic and manageable, with many patients living well for years after diagnosis.
- Review your pathology report and understand your tumor’s grade.
- ‘Watch and wait’ is sometimes the right path.
- Ask your care team about radioligand therapy and clinical trials.
Listen now on Apple, Spotify, YouTube and more
The full conversation is packed with insights on grading, treatments, side effects, and the critical role of patient advocacy.
If you or someone you know is facing a neuroendocrine tumor diagnosis, this episode is a must-listen.
Reminder: The content of MedInsights Unleashed is for informational purposes only and should not be considered medical advice. Always consult your healthcare provider for personalized guidance.
As always, thank you for your support!”
More posts featuring Zahra Ramji.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023